Checkpoint Therapeutics Inc (CKPT)
1.49
+0.10
(+7.19%)
USD |
NASDAQ |
May 02, 16:00
1.49
0.00 (0.00%)
After-Hours: 16:51
Checkpoint Therapeutics Total Liabilities (Quarterly): 18.42M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 18.42M |
| September 30, 2023 | 21.26M |
| June 30, 2023 | 31.61M |
| March 31, 2023 | 28.08M |
| December 31, 2022 | 32.77M |
| September 30, 2022 | 22.96M |
| June 30, 2022 | 24.62M |
| March 31, 2022 | 22.69M |
| December 31, 2021 | 25.98M |
| September 30, 2021 | 13.00M |
| June 30, 2021 | 9.249M |
| March 31, 2021 | 7.255M |
| December 31, 2020 | 7.217M |
| September 30, 2020 | 6.42M |
| June 30, 2020 | 7.711M |
| March 31, 2020 | 6.988M |
| Date | Value |
|---|---|
| December 31, 2019 | 8.119M |
| September 30, 2019 | 7.811M |
| June 30, 2019 | 8.014M |
| March 31, 2019 | 8.21M |
| December 31, 2018 | 13.09M |
| September 30, 2018 | 8.782M |
| June 30, 2018 | 6.655M |
| March 31, 2018 | 7.53M |
| December 31, 2017 | 6.372M |
| September 30, 2017 | 5.843M |
| June 30, 2017 | 4.107M |
| March 31, 2017 | 4.308M |
| December 31, 2016 | 3.673M |
| September 30, 2016 | 4.459M |
| December 31, 2015 | 4.258M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.42M
Minimum
Sep 2020
32.77M
Maximum
Dec 2022
16.32M
Average
13.00M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Fortress Biotech Inc | 165.94M |
| Anavex Life Sciences Corp | 12.50M |
| QuidelOrtho Corp | 3.557B |
| Processa Pharmaceuticals Inc | 0.7975M |
| Vera Therapeutics Inc | 73.86M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.378M |
| Shareholders Equity (Quarterly) | -13.05M |
| Current Ratio | 0.2919 |